Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Weller

Showing results (771-780 of 831) with videos related to

Pageof 84
Sort By:
Neuro-Oncology|March 14, 2022
Opportunities and challenges for the development of "core outcome sets" in neuro-oncologyChristopher P Millward, Terri S Armstrong, Heather Barrington, et al.
The Oncologist|January 22, 2026
Age and sex as risk factors for health-related quality of life outcomes in patients with glioma: a CODAGLIO 2.0 analysisOgechukwu A Asogwa, Linda Dirven, Neil K Aaronson, et al.
The Lancet. Oncology|December 5, 2019
EANO-EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastomaEnrico Franceschi, Silvia Hofer, Alba A Brandes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2022
A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in GlioblastomaSied Kebir, Vivien Ullrich, Pia Berger, et al.
Neuro-Oncology|November 4, 2024
Development and validation of a clinical risk model for postoperative outcome in newly diagnosed glioblastoma: A report of the RANO resect groupPhilipp Karschnia, Jacob S Young, Gilbert C Youssef, et al.
Neuro-Oncology|June 9, 2019
Barriers to accrual and enrollment in brain tumor trialsEudocia Q Lee, Ugonma N Chukwueke, Shawn L Hervey-Jumper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2026
Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform TrialPatrick Y Wen, Donald A Berry, Meredith B Buxton, et al.
Molecular Oncology|September 9, 2019
High-throughput proteomic analysis of FFPE tissue samples facilitates tumor stratificationYi Zhu, Tobias Weiss, Qiushi Zhang, et al.
Brain Pathology (Zurich, Switzerland)|April 21, 2020
cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and gradingDavid N Louis, Pieter Wesseling, Kenneth Aldape, et al.
Cancers|July 24, 2021
Development of Randomized Trials in Adults with Medulloblastoma-The Example of EORTC 1634-BTG/NOA-23Peter Hau, Didier Frappaz, Elizabeth Hovey, et al.
Pageof 84

Showing results (771-780 of 831) with videos related to

Sort By:
Pageof 84
Neuro-Oncology|March 14, 2022
Opportunities and challenges for the development of "core outcome sets" in neuro-oncologyChristopher P Millward, Terri S Armstrong, Heather Barrington, et al.
The Oncologist|January 22, 2026
Age and sex as risk factors for health-related quality of life outcomes in patients with glioma: a CODAGLIO 2.0 analysisOgechukwu A Asogwa, Linda Dirven, Neil K Aaronson, et al.
The Lancet. Oncology|December 5, 2019
EANO-EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastomaEnrico Franceschi, Silvia Hofer, Alba A Brandes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2022
A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in GlioblastomaSied Kebir, Vivien Ullrich, Pia Berger, et al.
Neuro-Oncology|November 4, 2024
Development and validation of a clinical risk model for postoperative outcome in newly diagnosed glioblastoma: A report of the RANO resect groupPhilipp Karschnia, Jacob S Young, Gilbert C Youssef, et al.
Neuro-Oncology|June 9, 2019
Barriers to accrual and enrollment in brain tumor trialsEudocia Q Lee, Ugonma N Chukwueke, Shawn L Hervey-Jumper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2026
Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform TrialPatrick Y Wen, Donald A Berry, Meredith B Buxton, et al.
Molecular Oncology|September 9, 2019
High-throughput proteomic analysis of FFPE tissue samples facilitates tumor stratificationYi Zhu, Tobias Weiss, Qiushi Zhang, et al.
Brain Pathology (Zurich, Switzerland)|April 21, 2020
cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and gradingDavid N Louis, Pieter Wesseling, Kenneth Aldape, et al.
Cancers|July 24, 2021
Development of Randomized Trials in Adults with Medulloblastoma-The Example of EORTC 1634-BTG/NOA-23Peter Hau, Didier Frappaz, Elizabeth Hovey, et al.
Pageof 84